Vytorins 5 billion in annual sales
March 31, 2008
– Comments (3) |
RELATED TICKERS: MRK
, SCP
Those of you who read my posts may possibly notice a subtle but consistent idea that the EPA and the FDA are to small=helpless=weak to be effective. This morning we all learned that Vytorin does not reduce heart disease. Apparently though, Merck and Schering-Plough learned this same information 730 mornings ago and did not feel that information was important enough to share. In fact, rather than mention that Vytorin did not reduce heart disease, they chose to spend $200,000,000.00 to say just how wonderful the drug is. And it sold. Lets just guess since there were 5bil in sales this year that their were 4bil in sales last year since the time Merck and SCP knew they were selling a product that did not help. Today the two companys took a combined 20bil loss in their market cap, I presume because they will no longer be selling Vytorin (I hope).
However I have some questions to ask MRK and SCP.
Will you be offering a full warrantee and refund for the money Medicare spent with you?
Have you budgeted for death benefits for people who needed real help and did not get it because they believed that your product was helping them?
Are you concerned about lawsuits?
I also have some questions for the FDA.
Do you consider Merck or Schering-Plough "to big to fail"?
Are you going to grow some balls?
RSS Headlines
Fool UK